TJP1 and non-alcoholic fatty liver: Previous laboratory studies have shown that D. officinale ultrafine powder (DOFP) could increase the expression of intestinal ZO-1 in convalescent nonalcoholic fatty liver model mice and regulate the abnormality of the intestinal-liver axis by inhibiting LPS-TLR4-related inflammation [18].